⚠️Educational purposes only. Not medical advice. Consult a licensed provider before use. Many peptides are research-grade compounds not FDA-approved. Verify legal status in your jurisdiction.
← Back to library
TB-500
Thymosin Beta-4 Fragment (LKKTETQ)
PreclinicalCategory 2 Banned
A fragment of Thymosin Beta-4 that promotes systemic tissue repair, cell migration, and deep healing.
Mechanism of action
Cell migration, actin regulation, angiogenesis, anti-inflammatory signaling
Primary benefits
- ✓Deep tissue repair
- ✓Tendon & ligament healing
- ✓Reduces inflammation
- ✓Improves flexibility
- ✓Systemic healing
Dosing
Beginner
2-2.5 mg twice weekly
Intermediate
5 mg twice weekly
Advanced
10 mg/week split
Frequency: 2x per week
Timing: Any time of day
Route: Subcutaneous injection, Intramuscular injection
Cycling protocol
Duration
4-6 weeks
Pattern
Continuous for injury duration
Break after
4 weeks
Important warnings
- ⚠️FDA Category 2 – banned from compounding (September 2024)
- ⚠️Use only under medical supervision